Michael Alvarsson
Overview
Explore the profile of Michael Alvarsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
22.
23.
Cornel J, Bakris G, Stevens S, Alvarsson M, Bax W, Chuang L, et al.
Diabetes Care
. 2016 Oct;
39(12):2304-2310.
PMID: 27742728
Objective: To evaluate chronic kidney disease (CKD) and cardiovascular outcomes in TECOS (Clinical trial reg. no. NCT00790205, clinicaltrials.gov) participants with type 2 diabetes and cardiovascular disease treated with sitagliptin, a...
24.
Wagner H, Fischer H, Degerblad M, Alvarsson M, Gustafsson T
Diab Vasc Dis Res
. 2016 Jun;
13(5):361-6.
PMID: 27325467
Purpose: Insulin sensitivity changes in response to exercise training demonstrate a large variation. Vascular endothelial growth factor A could promote increased insulin sensitivity through angiogenesis. We investigated associations between changes...
25.
Wagner H, Alvarsson M, Mannheimer B, Degerblad M, Ostenson C
Diabetes Care
. 2016 Jan;
39(3):345-52.
PMID: 26786573
Objective: There has been conflicting evidence regarding the potential role of vitamin D in glucose homeostasis. This study was designed to investigate the effect of high-dose vitamin D3 treatment on...
26.
Arnetz L, Hage C, Ekberg N, Alvarsson M, Brismar K, Norhammar A, et al.
Growth Horm IGF Res
. 2015 Aug;
25(6):298-303.
PMID: 26283275
Importance: Elevated cortisol levels and dysregulated insulin-like growth factor binding protein-1 (IGFBP-1; a marker of hepatic insulin sensitivity) are both related to insulin resistance and glucose abnormalities. It is unknown...
27.
Arnetz L, Ekberg N, Brismar K, Alvarsson M
Endocr Connect
. 2015 Mar;
4(2):92-9.
PMID: 25750212
Objective: Dysfunction of the hypothalamus-pituitary-adrenal (HPA) axis has been implicated in type 2 diabetes (T2D). The aim of this study was to investigate the impact of T2D and gender on...
28.
Pagels A, Hylander B, Alvarsson M
J Ren Care
. 2015 Mar;
41(3):187-94.
PMID: 25739425
Background: Diabetes is currently the most common cause of kidney disease among patients receiving renal replacement therapy. Pedagogical interventions to promote self-management and secondary prevention have been shown to be...
29.
Arnetz L, Ekberg N, Alvarsson M
Diabetes Metab Syndr Obes
. 2014 Sep;
7:409-20.
PMID: 25258546
Background: Women with type 2 diabetes (T2D) are less likely to reach the goals for hemoglobin A1c compared with men, and have higher all-cause mortality. The risk of cardiovascular disease...
30.
Lilja M, Jansson S, Alvarsson M, Aldrimer M, Nordin G, Attvall S
Lakartidningen
. 2014 Feb;
110(49-50):2246-8.
PMID: 24494398
No abstract available.